Ulcavis tabs 120mg #112

Pills Ulcavis instruction for use

Reed more and buy Ulcavis on this page

Composition and form of release

The drug Ulcavis is available in the form of tablets for oral administration in blister packs of 8 pieces (7) in a cardboard box, where an abstract is attached with a detailed description of the characteristics of the drug. Tablets are round, convex on both sides, covered with a protective film shell. Each tablet contains 120 mg of active ingredient - Bismuth oxide, as well as a number of auxiliary active ingredients: corn starch, magnesium stearate, povidone.

Indications for use

Tablets Ulcavis is prescribed for oral administration for the treatment of diseases of the gastrointestinal tract, namely:
    exacerbation of chronic peptic ulcer of the stomach and duodenum, including Helicobacter pylori caused by the bacterium;
    exacerbation of chronic gastritis or duodenitis;
    Diarrhea on the background of irritable bowel syndrome;
    functional diarrhea, not associated with diseases of the digestive tract.

Contraindications for Ulcavis

The pain in the stomach and the digestive function may be caused by various reasons, therefore, before starting therapy with Ulquavis, it is recommended that you undergo a comprehensive examination and take the necessary tests. Tablets Ulcavis can be taken only as prescribed by a doctor, contraindications to the use of the drug are:
    renal failure in the stage of decompensation;
    children under 4 years;
    individual intolerance to the components of the drug;
    lactation period;
    pregnancy.

Dosing and Administration

The drug Ulcavis taken orally, washed down with a small amount of water. The drug is taken half an hour before meals. The daily dose of the drug is divided into 2-4 admission. For adults, according to the instructions, 1 tablet is prescribed 4 times a day or 2 tablets 2 times a day. Children from 7 to 12 years are prescribed 1 tablet 2 times a day. For children from 4 to 7 years, the daily dose is calculated on an individual basis, depending on the characteristics of the body and the patient's body weight.
The duration of treatment with the drug is 1-2 months, depending on the severity of the symptoms of the disease and the presence of complications.
When the patient is diagnosed with Helicobacter pylori pilor the treatment with Ulcavis is combined with antibiotics or antibacterial agents, to which the sensitive bacterium is.

Application in pregnancy and lactation

The use of Ulcavis tablets during pregnancy is contraindicated, since there is no experience of using the drug and data confirming the safety of the medication for the fetus.
During breastfeeding, the drug should not be taken orally, since the active ingredient of the tablets is excreted in breast milk. If it is necessary to treat Ulcavis, lactation should be discontinued.

Adverse Events

The drug is well tolerated by patients following the recommended dosage in the instructions. In patients with hypersensitivity to the drug, there are sometimes side reactions, namely:
    on the part of the digestive system - dry mouth, epigastric pain, nausea, vomiting, constipation, bloating, increased gas production;
    allergic reactions - rash on the skin, hives, itching of the skin;
    from the side of the nervous system - encephalopathy, caused by the accumulation of bismuth in the blood plasma.
As a rule, all these side effects are poorly expressed and pass independently without harm to health.

Overdose

With prolonged use of the drug in high doses, the patient gradually develops signs of an overdose, which are clinically manifested by the following symptoms:
    impaired renal function;
    oppression of liver function;
    pathology from the central nervous system.
When symptoms of an overdose appear, treatment with the drug is stopped, the patient is washed with the stomach, prescribed drugs from the group of enterosorbents, saline laxatives, if necessary, symptomatically treated. If there is a marked violation of kidney function, it is advisable to conduct hemodialysis.

Drug Interactions

The drug is not recommended to appoint patients simultaneously with antacid agents, enterosorbents or enveloping. This drug interaction leads to a decrease in the therapeutic effect of Ulcavis. If a combination of these drug groups is necessary, a time interval of at least 4 hours between doses should be maintained.
With the simultaneous appointment of the drug Ulcavis with tetracyclines, it is possible to reduce absorption of the latter, which reduces the effectiveness of therapy.

special instructions for Ulcavis

Ulcavis tablets can not be taken for more than 8 weeks in a row. If the effectiveness of therapy is absent or insufficient, the patient should consult a doctor to correct the treatment and clarify the diagnosis.
During the period of therapy with Ulcavis, other medicines containing bismuth should not be taken, as this increases the risk of side effects and complications from the nervous system.
The drug is not prescribed for the treatment of gastrointestinal disease to children under 4 years of age, since there is no experience of use in this age category and no safety of the drug for the child has been established.
During therapy with the drug, patients can stain feces in a dark color and slightly darken the tongue, which is due to the content of bismuth in the preparation and is not an excuse for cancellation of treatment.
During the reception of tablets, it is not recommended to abuse dairy products, since they impair the absorption of bismuth by the body and reduce the therapeutic effect of the drug.
The drug Ulcavis does not affect the work of the central nervous system and the speed of psychomotor reactions.

Leave and storage conditions

You can buy Ulcavis without a prescription. Keep the tablets out of the reach of direct sunlight and moisture, away from children. The optimum temperature for storing the drug is 25 degrees. The shelf life of the tablets is indicated on the packaging and is 4 years from the date of manufacture.